Hutbti3_2_1
Hutbti3_2_1 Uses, Dosage, Side Effects, Food Interaction and all others data.
Hutbti3_2_1 is under investigation in clinical trial NCT02345070 (Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis).
Trade Name | Hutbti3_2_1 |
Generic | Romilkimab |
Romilkimab Other Names | Hutbti3_2_1, Romilkimab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Hutbti3_2_1